drugset / Trial / NCT01081483

A Study of Single Doses of ABT-072 in Japanese Healthy Male Adults

NCT01081483

Phase 1 Completed 24 enrolled Abbott Abbott Japan Co.,Ltd · collab
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of blinded, single ascending oral doses of ABT 072 under non-fasting conditions in healthy adult Japanese male subjects.

Timeline

Start
2010-03
Primary completion
2010-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator ABT-072 Small molecule 50 mg Oral